OAC
ELTX icon

OMERS Administration Corp’s Elicio Therapeutics ELTX Stock Holding History

OMERS Administration Corp’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$114K Sell
10,700
-12,800
-54% -$124K ﹤0.01% 998
2025
Q4 		$187K Buy
+23,500
New +$213K ﹤0.01% 920

Other funds holding ELTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OMERS Administration Corp's ELTX Position: Q1 2026 in Review

OMERS Administration Corp reduced its Elicio Therapeutics (ELTX) stake by 54% in Q1 2026, selling an estimated $124K and leaving 10,700 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #998.

OMERS Administration Corp first reported a position in ELTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $187K in Q4 2025. 47 funds tracked by Wall St. Rank hold ELTX as of Q1 2026.

  • OMERS Administration Corp held 10,700 shares of Elicio Therapeutics worth $114K as of Q1 2026.
  • OMERS Administration Corp sold 12,800 Elicio Therapeutics shares in Q1 2026, an estimated $124K.
  • Elicio Therapeutics made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #998 holding.
  • OMERS Administration Corp first reported a position in Elicio Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • OMERS Administration Corp's Elicio Therapeutics position peaked at $187K in Q4 2025.
  • 47 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.